Last 7 days
0.0%
Last 30 days
-5.2%
Last 90 days
43.7%
Trailing 12 Months
-41.6%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 403.2B | 94.9B | 0.11% | -12.25% | 22.47 | 4.25 | 1.25% | -14.07% |
LLY | 306.9B | 28.5B | 9.47% | 18.63% | 49.14 | 10.75 | 0.79% | 11.88% |
MRK | 272.8B | 59.3B | 0.39% | 32.42% | 17.88 | 4.63 | 21.72% | 11.27% |
PFE | 226.4B | 100.3B | -0.47% | -21.10% | 7.22 | 2.26 | 23.43% | 42.74% |
BMY | 145.0B | 46.2B | -1.10% | -5.44% | 22.92 | 3.14 | -0.49% | -9.54% |
MID-CAP | ||||||||
PRGO | 4.8B | 4.5B | -6.08% | -6.58% | -33.89 | 1.07 | 7.56% | -104.06% |
RETA | 3.3B | 2.2M | 188.80% | 191.52% | -10.55 | 1.5K | -80.71% | -4.88% |
SMALL-CAP | ||||||||
SUPN | 1.9B | 667.2M | -3.51% | 11.94% | 31.82 | 2.89 | 15.09% | 13.64% |
TLRY | 1.6B | 602.5M | -7.75% | -62.41% | -2.73 | 2.62 | 18.18% | -18.59% |
CGC | 855.6M | 478.9M | -23.48% | -77.89% | -0.27 | 1.79 | -31.50% | -634.70% |
INVA | 771.4M | 285.2M | -7.62% | -41.93% | 3.5 | 2.7 | -27.21% | -40.28% |
CRON | 719.3M | 114.5M | -12.90% | -53.56% | -4.26 | 6.28 | 27.90% | 57.40% |
ACRS | 555.5M | 29.8M | -33.15% | -52.78% | -6.39 | 18.67 | 340.05% | 4.35% |
OCUL | 398.4M | 51.5M | -14.57% | 2.18% | -5.61 | 7.74 | 18.32% | -984.05% |
ENDP | 94.1M | 2.3B | -43.99% | -88.43% | -0.03 | 0.04 | -22.53% | -376.66% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -1.4% | 4,757 | 4,825 | 4,828 | 4,703 | 4,483 |
Gross Profit | -1.1% | 1,556 | 1,574 | 1,640 | 1,591 | 1,534 |
S&GA Expenses | -0.2% | 855 | 857 | 844 | 802 | 768 |
R&D Expenses | -4.3% | 22.00 | 23.00 | 24.00 | 21.00 | - |
EBITDA | -1.4% | 761 | 772 | 860 | 843 | - |
EBITDA Margin | 0.0% | 0.16* | 0.16* | 0.18* | 0.18* | - |
Earnings Before Taxes | -0.2% | 504 | 505 | 605 | 615 | 756 |
EBT Margin | 1.2% | 0.11* | 0.10* | 0.13* | 0.13* | - |
Interest Expenses | -11.6% | -144 | -129 | -123 | -123 | -117 |
Net Income | -3.8% | 410 | 426 | 519 | 513 | 604 |
Net Income Margin | -2.4% | 0.09* | 0.09* | 0.11* | 0.11* | - |
Free Cahsflow | 21.2% | -371 | -471 | -221 | -110 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 9.2% | 11,147 | 10,205 | 10,507 | 10,322 | 10,203 |
Current Assets | 8.2% | 2,918 | 2,698 | 2,916 | 3,025 | 2,974 |
Cash Equivalents | 57.3% | 442 | 281 | 449 | 786 | 849 |
Inventory | 11.7% | 818 | 732 | 702 | 676 | 688 |
Net PPE | 13.0% | 3,579 | 3,167 | 3,127 | 2,820 | 2,727 |
Goodwill | 9.8% | 3,215 | 2,929 | 3,006 | 3,012 | 3,026 |
Liabilities | 13.3% | 6,235 | 5,505 | 5,712 | 5,690 | 5,722 |
Current Liabilities | 61.8% | 1,526 | 943 | 1,072 | 1,046 | 1,045 |
Long Term Debt | 3.0% | 4,221 | 4,098 | 4,171 | 4,157 | 4,191 |
Shareholder's Equity | 4.5% | 4,912 | 4,700 | 4,795 | 4,632 | 4,481 |
Retained Earnings | 15.1% | 619 | 538 | 538 | 350 | 209 |
Additional Paid-In Capital | 0.3% | 4,686 | 4,674 | 4,649 | 4,630 | 4,615 |
Accumulated Depreciation | 7.9% | 1,465 | 1,358 | 1,347 | 1,308 | 1,215 |
Shares Outstanding | 0% | 180 | 180 | 179 | 179 | 171 |
Float | - | 21,840 | - | - | - | - |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 78.8% | 329 | 184 | 439 | 504 | 441 |
Share Based Compensation | -1.9% | 51.00 | 52.00 | 54.00 | 55.00 | 60.00 |
Cashflow From Investing | 28.6% | -1,309 | -1,833 | -1,884 | -1,703 | -1,594 |
Cashflow From Financing | 2487.0% | 595 | 23.00 | 1,031 | 1,013 | 1,182 |
65.4%
55.8%
10.8%
Y-axis is the maximum loss one would have experienced if Catalent was unfortunately bought at previous high price.
13.5%
9.5%
8.6%
FIve years rolling returns for Catalent.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-27 | Neo Ivy Capital Management | added | 16,557 | 282,000 | 285,000 | 0.19% |
2023-03-23 | MetLife Investment Management, LLC | reduced | -0.81 | -1,375,980 | 2,216,470 | 0.02% |
2023-03-17 | American Portfolios Advisors | added | 5.72 | -30,144 | 74,893 | -% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 17.75 | -1,463,000 | 4,004,000 | -% |
2023-03-06 | NORTH STAR ASSET MANAGEMENT INC | added | 17.63 | -1,140,120 | 3,109,880 | 0.19% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -74.97 | -6,635,000 | 1,222,000 | 0.01% |
2023-02-28 | Voya Investment Management LLC | added | 30.19 | -3,101,880 | 13,205,100 | 0.02% |
2023-02-24 | NATIXIS | sold off | -100 | -2,339,000 | - | -% |
2023-02-24 | National Pension Service | reduced | -99.98 | -18,756,100 | 2,025 | -% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | -456,000 | 752,000 | 0.01% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | t. rowe price investment management, inc. | 9.2% | 16,578,946 | SC 13G/A | |
Feb 13, 2023 | capital world investors | 7.7% | 13,914,820 | SC 13G/A | |
Feb 09, 2023 | janus henderson group plc | 4.6% | 8,216,242 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 10.88% | 19,588,103 | SC 13G/A | |
Feb 07, 2023 | blackrock inc. | 7.7% | 13,788,094 | SC 13G/A | |
Jan 27, 2023 | veritas asset management llp | 6.21% | 11,169,815 | SC 13G | |
Feb 14, 2022 | price t rowe associates inc /md/ | 10.8% | 18,616,482 | SC 13G/A | |
Feb 11, 2022 | capital world investors | 6.2% | 10,577,293 | SC 13G | |
Feb 09, 2022 | vanguard group inc | 10.79% | 18,479,271 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 8.8% | 14,998,086 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 52.48 -20.41% | 66.72 1.19% | 94.66 43.57% | 131.81 99.91% | 165.84 151.52% |
Current Inflation | 48.38 -26.62% | 60.51 -8.23% | 83.99 27.38% | 115.25 74.79% | 143.74 118.00% |
Very High Inflation | 43.32 -34.30% | 53.04 -19.56% | 71.45 8.36% | 96.07 45.70% | 118.36 79.51% |
Date Filed | Form Type | Document | |
---|---|---|---|
Feb 21, 2023 | 3 | Insider Trading | |
Feb 14, 2023 | SC 13G/A | Major Ownership Report | |
Feb 13, 2023 | SC 13G/A | Major Ownership Report | |
Feb 09, 2023 | SC 13G/A | Major Ownership Report | |
Feb 09, 2023 | SC 13G/A | Major Ownership Report | |
Feb 07, 2023 | SC 13G/A | Major Ownership Report | |
Feb 07, 2023 | 8-K | Current Report | |
Feb 07, 2023 | 10-Q | Quarterly Report | |
Feb 06, 2023 | 3 | Insider Trading | |
Jan 27, 2023 | SC 13G | Major Ownership Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-01-23 | Hopson Ricky | sold | -31,738 | 49.36 | -643 | pres. clinical dev supply div |
2022-12-05 | Boerman Manja | sold | -40,326 | 51.7 | -780 | pres. biomodalities division |
2022-10-31 | Grippo Michael J | sold | -161,349 | 65.83 | -2,451 | svp, strategy & corp. dev. |
2022-10-27 | Barber Michael J | acquired | - | - | 4,149 | - |
2022-10-27 | GREISCH JOHN J | acquired | - | - | 4,149 | - |
2022-10-27 | Balachandran Madhavan | acquired | - | - | 4,149 | - |
2022-10-27 | MOREL DONALD E JR | acquired | - | - | 4,149 | - |
2022-10-27 | CLASSON ROLF A | acquired | - | - | 4,149 | - |
2022-10-27 | Kreuzburg Christa | acquired | - | - | 4,149 | - |
2022-10-27 | STAHL JACK L | acquired | - | - | 4,149 | - |
Consolidated Statements of Operations - USD ($) $ in Millions | 3 Months Ended | |||||
---|---|---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | |||||
Income Statement [Abstract] | ||||||
Net revenue | $ 1,022.0 | $ 1,025.0 | ||||
Cost of sales | 764.0 | 701.0 | ||||
Gross margin | 258.0 | 324.0 | ||||
Selling, general, and administrative expenses | 196.0 | 183.0 | ||||
Payments for (Proceeds from) Businesses and Interest in Affiliates | [1] | 0.0 | (1.0) | |||
Other Cost and Expense, Operating | 2.0 | 4.0 | ||||
Operating earnings | 60.0 | 138.0 | ||||
Interest expense, net | 32.0 | 26.0 | ||||
Other (income)/expense, net | [2] | 25.0 | 9.0 | |||
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total | 3.0 | 103.0 | ||||
Income tax expense | 3.0 | 10.0 | ||||
Net earnings/(loss) | 0.0 | 93.0 | ||||
Participating Securities, Distributed and Undistributed Earnings (Loss), Basic | 0.0 | 9.0 | ||||
Net Income (Loss) Available to Common Stockholders, Basic | $ 0.0 | $ 84.0 | ||||
Earnings Per Share, Basic | $ 0 | $ 0.49 | ||||
Earnings Per Share, Diluted | $ 0 | $ 0.49 | ||||
|
Consolidated Balance Sheets - USD ($) $ in Millions | Sep. 30, 2022 | Jun. 30, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 281 | $ 449 |
Trade receivables, net | 989 | 1,051 |
Inventories | 732 | 702 |
Prepaid expenses and other | 632 | 625 |
Marketable Securities | 64 | 89 |
Total current assets | 2,698 | 2,916 |
Property, plant, and equipment, net | 3,167 | 3,127 |
Other assets: | ||
Goodwill | 2,929 | 3,006 |
Other intangibles, net | 1,017 | 1,060 |
Deferred Income Tax Assets, Net | 45 | 49 |
Other Assets, Noncurrent | 349 | 349 |
Total assets | 10,205 | 10,507 |
Current Liabilities: | ||
Debt, Current | 106 | 31 |
Accounts payable | 379 | 421 |
Other accrued liabilities | 458 | 620 |
Total current liabilities | 943 | 1,072 |
Long-term obligations, less current portion | 4,098 | 4,171 |
Pension liability | 98 | 103 |
Deferred Income Taxes | 214 | 202 |
Other liabilities | 152 | 164 |
Total liabilities | 5,505 | 5,712 |
Temporary Equity, Carrying Amount, Attributable to Parent | $ 0 | $ 0 |
Common Stock, Par or Stated Value Per Share | $ 0.01 | $ 0.01 |
Common Stock, Shares Authorized | 1,000,000,000 | 1,000,000,000 |
Common Stock, Value, Outstanding | $ 2 | $ 2 |
Preferred Stock, Value, Outstanding | 0 | 0 |
Additional paid in capital | 4,674 | 4,649 |
Accumulated deficit | 538 | 538 |
Accumulated other comprehensive income/(loss) | (514) | (394) |
Total shareholders' equity | 4,700 | 4,795 |
Total liabilities, redeemable preferred stock, and shareholders’ equity | $ 10,205 | $ 10,507 |
Common stock, shares issued (shares) | 180,000,000 | 179,000,000 |